COMPANY

RareCyte

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $658K (SBIR Phase II 5R44CA298064-02, continuation, notice Jul 17, 2026). NIH RePORTER 5R44CA298064-02 (Jul 17, 2026)
Evidence (1 event)
- Jul 17, 2026 · NIH RePORTER 5R44CA298064-02
  Organization: RARECYTE, INC.; City/State: SEATTLE, WA; Project number: 5R44CA298064-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-17; FY total cost (award amount): 658336; Administering IC: National Cancer Institute; Project title: Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jul 17, 2026 Grant Government grant — SBIR: $658,336 (annual award, as published), announced Jul 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
May 20, 2025 Grant Government grant — SBIR: $658,336 (annual award, as published), announced May 20, 2025. Agency: NIH/NCI. Source: government award database. source ↗

Last 2 years.

Jul 17, 2026 Government grant — SBIR: $658,336 (annual award, as published), announced Jul 17, 2026. Agency: NIH/NCI. Source: government award database. source ↗
May 20, 2025 Government grant — SBIR: $658,336 (annual award, as published), announced May 20, 2025. Agency: NIH/NCI. Source: government award database. source ↗